Ausgabe 4/2004
Inhalt (13 Artikel)
Monoclonal antibodies in the treatment of chronic lymphocytic leukemia
Nina Shih Liu, Susan O’Brien
Two- vs three-drug combination chemotherapy in advanced or recurrent head and neck cancer
V. R. Pai, T. Mazumdar, C. D. Deshmukh, A. V. Bakshi, D. M. Parikh, P. M. Parikh, R. C. Mistry, K. A. Pathak, A. K. D’Cruz
Tamoxifen and megestrol acetate for postmenopausal breast cancer
L. Löfgren, B. Wallberg, N. Wilking, T. Fornander, L. E. Rutqvist, K. Carlström, B. von Schoultz, E. von Schoultz
Sequence variant in the intron 10 of the RET oncogene in a patient with microfollicular thyroid carcinoma with medullar differentiation
Emilija Veljkovic, Radan Dzodic, Gorana Neskovic, Boban Stanojevic, Zorka Milovanovic, Miroslav Opric, Bogomir Dimitrijevic
Myelofibrosis in primary myelodysplastic syndromes
D. Marisavljević, Z. Rolović, V. Ćemerikić, D. Bošković, M. Ćolović
Long-term survivors in myelodysplastic syndromes
Dragomir Marisavljević, Zoran Rolović, Darinka Bošković, Milica Čolović
Synergistic effects of combination therapy employing antisense oligonucleotides with traditional chemotherapeutics in the PC-3 prostate cancer model
Paulus Tsui, Marvin Rubenstein, Patrick Guinan
Serial monitoring of BCR-ABL transcripts in chronic myelogenous leukemia (CML) treated with imatinib mesylate
Mats Hardling, Yuan Wei, Lars Palmqvist, Birgitta Swolin, Dick Stockelberg, Bengt Gustavsson, Kerstin Ekeland-Sjöberg, Hans Wadenvik, Anne Ricksten
Ifosfamide, mesna, and interferon-alpha2A combination chemoimmunotherapy in malignant mesothelioma
Mustafa Altinbas, Ozlem Er, Metin Ozkan, Hasan Senol Coskun, Inci Gulmez, Eyup Ekici, Bunyamin Kaplan, Bulent Eser, Mustafa Ozesmi
Epithelioid sarcoma of vulva
Kadri Altundag, Oguz Dikbas, Basak Oyan, Alp Usubutun, Alev Turker
Acute leukemia in a patient with ocular melanoma
Mustafa Ozguroglu, Nuran Bese, Songül Karacam, Halit Pazarlı